The healthcare landscape for glucose is evolving, and transdermal GLP-1 delivery systems represent a potential advance. Unlike injections, this approach offers a simpler way to provide GLP-1 drugs. These devices https://emilyczba873607.onzeblog.com/41171012/glp-1-patches-a-new-approach-to-diabetes-control